ASEM documentary overview
Official National Advisory Committee on Immunization document (2022) on “Archived 46: Summary of NACI statement of October 21, 2022: Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age”. Summary of NACI recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years, including summary of evidence, clinical trial and safety data, authorized preparations and schedule.
This overview helps you identify the document. Always consult the current official publication for clinical recommendations.
Official document